Ca
. The onset of inhibition during enzyme cycling was observed over a period of seconds, revealing the existence of a low inhibition rate constant. It is concluded that cyclopiazonic acid decreases enzyme affinity for ATP in non-turnover conditions by approximately one order of magnitude. This allows enzyme cycling after drug binding, provided that a high ATP concentration is used. Cyclopiazonic acid and ATP do not compete for the same binding site.
Cyclopiazonic acid (CPA)
1 is a mycotoxin produced by certain strains of Penicillium cyclopium and Aspergillus flavus. This indole tetramic acid with the molecular formula C 20 H 20 N 2 O 3 was first isolated in 1968 (1) . It may be found as a natural contaminant in some cereal products and mold-fermented cheese and meat (2) , representing a potential risk to human and animal health. The clinical signs of CPA toxicity are usually related to muscle functionality, suggesting a direct effect of CPA on this tissue (3) . By using isolated SR vesicles from skeletal muscle, it was proved that CPA is a potent inhibitor of both Ca 2ϩ -ATPase activity and ATP-dependent Ca 2ϩ transport (4) . The specificity of CPA for SR Ca 2ϩ -ATPase and not for other cation ATPases was also established (5) . CPA, along with thapsigargin (TG) and 2,5-di(tert-butyl)-1,4-benzohydroquinone, are three structurally unrelated compounds that constitute a group of highly specific inhibitors of SERCA proteins (6) .
Selective inhibition by CPA has been exploited in countless reports (for examples, see Refs. [7] [8] [9] [10] [11] [12] to analyze Ca 2ϩ signaling mechanisms. Indeed, a detailed characterization of the CPA action is a critical aspect in the manipulation of intracellular Ca 2ϩ stores and may be helpful in providing information on the Ca 2ϩ -ATPase energy transduction mechanism. The literature available does not provide a satisfactory description of the CPA effect. For instance, an initial report indicated that the Ca 2ϩ -ATPase inhibition was essentially complete at stoichiometric amounts of CPA; however, the type of inhibition was studied in the range of 10 -100 nmol CPA/mg of protein (5) .
The present study was devoted to clarify the effect of CPA when the drug was used in the stoichiometric range with respect to the enzyme concentration. To this end, a series of measurements on enzyme turnover were performed to elucidate the functional characteristics of the CPA interaction. Ligand binding at equilibrium by using radioactive ATP and TNP-ATP fluorescence allowed us to decipher the relationship between the ATP-and the CPA-binding sites. Measurements of radioactive EP, including different conformational states of the protein, preincubation conditions, and reaction schedules shed light on the enzyme behavior with respect to protection, sensitivity, and onset of inhibition by CPA. All of these data are compiled in a functional model and are discussed with respect to the well characterized inhibitor TG.
EXPERIMENTAL PROCEDURES

Materials-[␥-
32 P]ATP was obtained from Amersham Corp. and used at a specific activity of approximately 20,000 cpm/nmol. CaCl 2 were products of DuPont NEN. They were used at ϳ3,000 and ϳ15,000 cpm/nmol, respectively. The Ca 2ϩ ionophore A23187 was purchased from Boehringer Mannheim. TNP-ATP was from Molecular Probes Europe, The Netherlands. The liquid scintillation mixture was Sigma-Fluor (S-4023) from Sigma. A stock solution of cyclopiazonic acid from Penicillium cyclopium (Sigma) was prepared in ethanol. The volume of ethanol added did not exceed 1% of the total volume. CPA was always added to the incubation/reaction media after the SR vesicles, which were then preincubated for at least 5 min before the reactions were started.
Membrane Preparation and Quantitation-Sarcoplasmic reticulum vesicles from fast-twitch muscle of rabbit hind leg were prepared according to Eletr and Inesi (13) and stored in frozen aliquots until use. The membrane protein concentration was determined by the colorimet-* This work was supported by Grant PB94-1164 (to F. F. B.) from Direccion General de Investigacion Cientifica y Tecnica, Spain. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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§ To whom correspondence should be addressed. (Claix, France) by using a 150-watt mercury-xenon lamp. The experimental protocol was essentially as described previously (20) . The excitation wavelength was 410 nm, and the emission light was selected with a 515-nm cutoff filter (Ealing Electro-Optics, Holliston, MA). Samples were maintained at 22°C under continuous stirring. The incubation medium contained 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl 2 , 0.2 mM EGTA, 0.1 mg/ml SR protein, and 2 M TNP-ATP in the absence or presence of CPA. The decrease in fluorescence was elicited by successive additions of ATP.
Enzyme Phosphorylation by ATP-The phosphorylated intermediate of the enzyme was studied by using [␥- 32 P]ATP as a substrate. Unless otherwise stated, all the reactants were preincubated in an ice-water bath before the reactions were initiated. The phosphorylation reaction was started by manual mixing under vortexing of the enzyme suspension with the radioactive ATP and stopped by the addition of 1 volume of ice-cold perchloric acid (0.25 M) plus sodium phosphate (2 mM). The quenched samples were filtered under vacuum using 0.45-m pore size Millipore filters (type HAWP), and the filters were then washed five times with 5 ml of 0.125 M perchloric acid and 1 mM sodium phosphate. The filters were subjected to radioactive counting after solubilization in 3 ml of liquid scintillation mixture. Different enzymatic forms, reaction media, and experimental schedules were applied to study the effect of CPA as follows:
(i) Maximal levels of EP initiated from E 1 Ca 2 . The microsomal vesicles (0.2 mg protein/ml) were suspended in the presence of 20 mM Mops, 
RESULTS
CPA, Binding Experiments, and Enzyme
Turnover-The inhibition of SERCA activity is critically dependent on enzyme, ATP, and CPA concentrations (5); therefore, we initially studied the CPA/enzyme stoichiometry under our experimental conditions. The steady-state rate of enzyme activity as a function of SR protein concentration was measured at 25°C in leaky vesicles in the presence of an ATP-regenerating system and a fixed ATP concentration of 50 M. As can be seen in Fig. 1 , the rate of ATP hydrolysis was linearly dependent on the membrane protein concentration (E). When the experiments were repeated in the presence of CPA, the linear dependence of the enzyme activity was delayed. This effect was more evident for a CPA concentration of 0.25 M (q) than for a concentration of 0.1 M (å), which is clear proof of high affinity inhibition. An abscissa intersection value of 0.025 mg/ml was obtained in the experiments with 0.1 M CPA and 0.055 mg/ml in the presence of 0.25 M CPA. The asymptote intersection with the abscissa axis provides information on the drug/enzyme stoichiometry. Thus, a drug:enzyme molar ratio of approximately 1:1 can be deduced, assuming from the maximal EP level that 1 mg of SR protein contains ϳ4 nmol of Ca 2ϩ -ATPase active sites. It was published previously that ATP counteracts the inhibitory effect of CPA (5). Therefore, we studied whether CPA 
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perturbed the interaction of ATP with the enzyme by measuring the equilibrium binding of ATP to the nonphosphorylated enzyme ( Fig. 2A) . The assay was carried out in the presence of EGTA to prevent any ATP hydrolysis. Protein concentration was 0.2 mg/ml, and radioactive ATP was used as a tracer. The ATP-binding isotherm in the absence of CPA (E) indicates a single population of ATP-binding sites with a maximal binding capacity of ϳ4 nmol/mg protein and an apparent K d of ϳ3 M, which is in agreement with previous reports (20, 21) . When the experiments were performed in the presence of 0.3 or 0.8 M CPA, there was a progressive increase in the half-maximal ATP concentration necessary for saturating the high affinity binding sites. It was not possible to measure the saturation level in the presence of CPA due to unspecific low affinity ATP binding (21) . Nevertheless, the high affinity ATP sites can be characterized by a Scatchard plot (Fig. 2B) . The titration curve in the presence of 0.3 M CPA displayed a biphasic pattern (Fig.  2B, inset) , confirming the existence of two different ATP-binding populations (enzyme with and without CPA) at substoichiometric drug concentrations. The apparent K d for ATP in the presence of CPA (the lower affinity component) can be more easily evaluated when the enzyme is saturated by the drug (i.e. with 0.8 M CPA, equivalent to 1 mol of CPA/mol of enzyme).
Under these conditions, we found a single population of ATP sites with maximal binding of 4 nmol/mg of protein and an apparent K d of ϳ 28 M (Fig. 2B, main panel) .
To complement the preceding data and also to test CPA concentrations above the stoichiometric level, we took advantage of the fluorescent probe TNP-ATP (22, 23) . The binding of TNP-ATP to the enzyme in the absence of Ca 2ϩ is accompanied by a specific fluorescence increase. An indirect titration of the catalytic site can be obtained by the subsequent sequential addition of ATP because the change in relative fluorescence can be correlated with nanomoles of ATP bound to the enzyme (20, 24) . The results (Fig. 3) confirmed that CPA increases the half-maximal concentration necessary for saturating the ATPbinding sites and also that maximal ATP binding can reach the level observed in the absence of drug. Moreover, CPA lowered the Hill coefficient of the ATP-binding curve, when the CPA: enzyme molar ratio was Ͻ1. This is illustrated by comparing the fluorescence isotherm in the absence of CPA (E) and that obtained at 0.25 M CPA (f). The selected CPA concentration represents approximately 60% enzyme saturation by the drug because the SR protein concentration was 0.1 mg/ml. We also extended our measurements to 0.4 (q) and 1.2 M CPA (å), representing 1 or 3 mol of CPA/mol of enzyme, respectively. It is noteworthy that the half-maximal saturation in the fluorescence isotherms was independent of CPA when the CPA/enzyme was Ն1. Likewise, the ATP binding cooperativity reverted to a Hill coefficient of approximately 1 when the enzyme was saturated by CPA.
We also studied the Ca 2ϩ -ATPase activity as a function of the ATP concentration after incubation of the nonphosphorylated enzyme with CPA. The drug concentration was selected to give the same CPA:enzyme molar ratios used in the ATP-binding experiments of (Fig. 2) . The reaction medium contained a protein concentration of 0.02 mg/ml and included Ca 2ϩ ionophore and an ATP-regenerating system to permit steady-state conditions at ATP concentrations as low as 1 M. The results of (Fig.  4A) indicate that samples incubated in the absence of CPA (E) exhibit the expected increase of enzyme activity with increasing concentrations of ATP. The presence of 0.03 M (å) or 0.08 M CPA (q) produced a progressive decrease in the apparent enzyme affinity for ATP and maximal hydrolytic activity. Note that in the presence of 0.08 M CPA, a stoichiometric concentration of the drug, the enzyme may express hydrolytic activity, provided that the ATP concentration is high enough. It is relevant that CPA concentrations above stoichiometric levels led to further decreases in enzyme activity (data not shown). Enzyme activity data obtained at the higher ATP concentra- 
tions were also analyzed in a double reciprocal plot (Fig. 4B) . The absence of a common intersection point on the ordinate axis confirms that the V max value is dependent on the CPA concentration.
CPA and Reaction Cycle-It was shown previously by using the extrinsic fluorescence of fluorescein-5Ј-isothiocyanate that CPA stabilizes the E 2 form of the enzyme (5, 25) . This observation on enzyme conformational states can be more deeply analyzed by considering the basic molecular transitions involved in the Ca 2ϩ -ATPase reaction cycle (see Scheme I). Thus, the reactivity of the E 1 form toward ATP can be monitored by following the phosphorylation partial reaction (step 2). For this purpose, 0.2 mg/ml SR vesicles preequilibrated with saturating Ca 2ϩ (E 1 Ca 2 ) were supplemented with CPA up to 1 M, and the accumulated EP was studied at 0°C by measuring the 32 P covalently bound to the protein after addition of [␥-
32 P]ATP. The EP level reached the same maximal levels as those obtained in the absence of drug (Fig. 5) . The phosphorylation reaction was also performed at 0°C and maintained for 5 s as before. Using this protocol, we can study the sequence of steps 1 and 2. In this case, the presence of increasing CPA concentrations produced a progressive inhibition of the radioactive EP level (Fig. 6) .
The time course of the accumulated EP was also considered in the next assay. The experiment was performed at 22°C and involved the addition of CPA to the enzyme in the presence of Ca 2ϩ , before mixing with radioactive ATP. The reaction was stopped at various time intervals by the addition of acid. The ATP concentration was relatively high (400 M) to permit observation of the EP time course on the scale of minutes. This also permitted detection of enzyme turnover in the presence of 0.8 M CPA (a stoichiometric concentration). As illustrated by (Fig. 7) , CPA inhibition can be elicited by allowing enzyme turnover. The EP hydrolytic cleavage was monophasic until complete exhaustion of the substrate in the absence of CPA. However, when CPA was present, there was a clear biphasic response. Enzyme inhibition manifested as an initial transient decay of EP followed by a lasting steady-state level. As a result of the inhibition, the ATP was not completely consumed in the same time span as in the control experiment. The different temperature used may also explain why the EP level measured at the shorter phosphorylation times was lower than the control value obtained in Fig. 6 . We then studied inhibition of the cycling enzyme as a function of different CPA concentrations. The reaction medium was modified to maintain enzyme turnover in the minute time scale without the necessity of adding high concentrations of radioactive ATP. CPA was added to the enzyme in the presence of Ca 2ϩ , as before, but the phosphorylating substrate was now 50 M nonradioactive ATP. The reaction mixture also contained an ATP-regenerating system to ensure enzyme turnover during the assay. After a phosphorylation period of 3 min at 22°C, EP labeling was detected by adding a pulse of [␥-32 P]ATP followed by acid quenching at 2 s. Fig. 8 shows that the accumulated EP under steady-state conditions decreased as a function of the CPA concentration. The degree of inhibition at 0.8 M CPA was higher than in the experiment of Fig. 7 because of the presence of a lower ATP concentration.
The last set of experiments was directed toward establishing whether ATP had any protective effect when CPA was added to the enzyme in the E 2 form. In the experiment outlined in 2ϩ was added to initiate enzyme phosphorylation. The reaction was carried out at the ice-water temperature for 2 s. The observed inhibition resembles that obtained when CPA was directly added to the enzyme in the absence of ATP and Ca 2ϩ (compare Fig. 6 ). EP decreased progressively as the CPA concentration rose. However, for a given CPA concentration, the EP level was higher in the experiment performed in the presence of the higher ATP concentration.
DISCUSSION
The experiments reported above are helpful for understanding the functional properties of CPA as inhibitor of the SERCA family of proteins. It should be stressed that the present study has been restricted to stoichiometric and substoichiometric CPA concentrations. Because different CPA:enzyme molar ratios have been reported (5, 25) as producing complete inhibition of the Ca 2ϩ -ATPase activity, our first concern was to re-examine this parameter under well defined assay conditions. A plot of enzyme activity versus membrane protein concentration (Fig. 1) , or the inhibitory effect of CPA on EP formation (Fig. 6) , indicated a 1:1 stoichiometry with respect to active sites on the enzyme. Therefore, the number of CPA-binding sites is equivalent to that of the high affinity ATP-binding sites. The stoichiometric value is somewhat lower than that originally reported (6 -8 nmol CPA/mg of protein) at low ATP concentrations (5) . Small changes in the experimental conditions, including the purity of the membrane protein preparation or the methods used for the binding site estimation, may account for the observed difference.
When the enzyme is completely saturated by CPA, the Scatchard plot (Fig. 2B) indicates the existence of a single ATPbinding population. This is consistent with the binding cooperativity data (Fig. 3) showing a Hill coefficient of approximately 1. However, when the enzyme is partially saturated by CPA, there are two nucleotide binding populations (Fig. 2B, inset) and negative cooperativity (Fig. 3) . The apparent K d for ATP in the presence of CPA can be graphically estimated from a Scatchard plot, and the evaluation is easier when the enzyme is completely saturated by CPA (Fig. 2B , compare data points in main panel and low affinity component in the inset). Furthermore, the half-maximal ATP concentration necessary for saturating the high affinity sites will only give information on the apparent K d when CPA:enzyme is Ն1. In any case, CPA reduced the apparent K d for ATP by approximately one order of magnitude. This may explain why other phosphorylating sub- 
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strates such as acetylphosphate, which has lower affinity for the enzyme, cannot be hydrolyzed after incubation with CPA (5). Interestingly, the effect of TG as a SERCA inhibitor is similar because TG also decreases the binding affinity of ATP (20) . This effect may explain the observed ATP binding inhibition induced by TG (26) . A decrease in the binding affinity at the phosphorylation site promoted by TG would also account for the loss in the phosphorylating capacity of P i (27, 28) . Earlier studies have claimed a competitive relationship between CPA and ATP (5, 25) . However, our ATP-binding experiments indicate that the observed decrease in the K d for ATP is independent of CPA. Certainly, this observation cannot be reconciled with a direct competition between CPA and ATP. Furthermore, CPA does not modify the TNP-ATP fluorescence signal, suggesting that the ligands do not interact at the same binding site. This property is shared by TG. Studies on TNP-ATP fluorescence suggested that the interaction of TG with the protein was not at the ATP-binding site (20) .
The reversal of CPA inhibition by increasing the ATP concentration has been interpreted as a protective effect of ATP and attributed to a competitive effect (5) . From the present data (Figs. 2-4) , it is apparent that CPA simply decreases the K d for ATP so that the enzyme will express higher hydrolytic activity if ATP concentration is increased. A similar effect of ATP was also observed in the EP measurements of Fig. 9 . Before it can be assured that CPA is a competitive inhibitor, it must be demonstrated that the Ca 2ϩ -ATPase activity in the presence of CPA can reach the maximal velocity measured in the absence of drug. A direct plot of enzyme activity versus ATP concentration (Fig. 4A) indicates that this is not the case. Double reciprocal plots of data conforming a high affinity inhibition mechanism give concave-down curves that are difficult to analyze (29) . However, by plotting enzyme activity data obtained at the higher ATP concentrations, we were able to analyze the region near the 1/v axis in more detail. Fig. 4B confirms that CPA does not behave as a competitive inhibitor. The conclusion that CPA is a competitive inhibitor (5) was based on the analysis of nonlinear double reciprocal plots showing a poor resolution in the region near the ordinate axis. Furthermore, the experiments were performed at CPA concentrations (10 -100 nmol/mg of protein), much higher than the stoichiometric level. In another study (25) , a Dixon plot was the only experimental evidence offered to support the competitive character of CPA. This plot provides information on the K i value but cannot be used to diagnose the type of inhibition.
The Ca 2ϩ -ATPase activity isotherms shown in Fig. 4A indicate that the enzyme may undergo turnover in the presence of stoichiometric CPA at high ATP concentrations. However, enzyme turnover displayed lower ATP affinity (KЈ ATP ) and lower maximal velocity (VЈ max ) than in the absence of CPA. Consequently, when the CPA concentration is in the substoichiometric level, the observed kinetic parameters will correspond to the simultaneous contribution of two different reaction cycles sustained by the enzyme without CPA (K ATP and V max ) and the enzyme with CPA (KЈ ATP and VЈ max ). The inhibition of the SERCA activity by CPA can be illustrated by Scheme II. In this model, CPA does not interact with the E 1 form, and the binding of CPA to E 2 does not take place at the catalytic site. When CPA was in excess with respect to the enzyme protein concentration, there was a higher degree of inhibition. This suggests that the CPA effect is not restricted to the ATP-binding process, although this was not investigated further.
The phosphorylation of E 1 Ca 2 by ATP was not altered by CPA (Fig. 5) ; hence, the catalytic site is probably not the drug target. This suggests that E 1 is refractory to CPA. However, when the reaction cycle was started from E 2 , the addition of CPA inhibited EP formation (Fig. 6) , suggesting a selective effect of CPA on the E 2 form. This is in agreement with previous fluorescence measurements of the protein conformational states (5) . The protective effect of Ca 2ϩ on E 1 can be eliminated by adding ATP. This is an indication that the enzyme turnover generates an intermediate species that is susceptible to CPA. No inhibition was observed in the presence of 50 M ATP because EP decay took place over a short time span (data not shown). However, the inhibition becomes clear when the EP evolution was studied in the presence of a relatively high ATP concentration (400 M) to allow enzyme turnover on a time scale of minutes (Fig. 7) . The data of Figs. 7 and 8 reveal that the onset of inhibition during the enzyme turnover is a rather slow process. This implies that a high number of reaction cycles is required for enzyme inhibition to be observed. It can be postulated that after the initial binding of CPA to the enzyme, there is a slow isomerization step leading to an E 2 state with a lower ATP binding affinity. The data for TG indicated that enzyme inhibition is also associated with the E 2 conformation (28). TG inhibition by adding ATP also developed over seconds (30) , although it was faster than in the case of CPA inhibition.
An important difference between CPA and TG is that the latter causes a drastic decrease in the apparent K d for both ATP and Ca 2ϩ , producing for practical purposes a dead-end complex (26 -28) . The present data indicate that CPA diminishes ATP binding affinity but to a lesser extent than TG. Therefore, the enzyme with CPA bound can be forced to undergo turnover by increasing ATP concentration.
Location of the CPA-binding site will throw light on the role played by the region of the SERCA proteins that is recognized by the drug. This may be achieved from the construction of chimeric proteins as was done for the location of the TG target site (31) .
